Peripheral Blood Stem Cell TransplantationBone Marrow TransplantationHematopoietic Stem Cell TransplantationTransplantation, AutologousHematopoietic Stem Cell MobilizationBone MarrowTransplantation, HomologousBone Marrow CellsGranulocyte Colony-Stimulating FactorLeukapheresisGraft vs Host DiseaseHematopoietic Stem CellsStem CellsTransplantation ConditioningBlood Component RemovalHematologic NeoplasmsAntigens, CD34Graft SurvivalCyclophosphamideCombined Modality TherapyTissue DonorsMelphalanWhole-Body IrradiationBusulfanLeukemiaBone and BonesMultiple MyelomaStem Cell TransplantationTreatment OutcomeBlood CellsAnemia, AplasticAntineoplastic Combined Chemotherapy ProtocolsHematopoiesisHistocompatibilityHistocompatibility TestingRecurrenceTransplantation ChimeraLymphoma, Non-HodgkinBone Marrow PurgingBone Marrow DiseasesCytomegalovirus InfectionsCord Blood Stem Cell TransplantationBlood Cell CountImmunosuppressive AgentsTime FactorsRemission InductionLeukemia, Myeloid, AcuteMyeloablative AgonistsThiotepaEtoposideRetrospective StudiesLeukemia, Myelogenous, Chronic, BCR-ABL PositiveAntineoplastic Agents, AlkylatingTransplantation, IsogeneicOpportunistic InfectionsColony-Forming Units AssayInfectionDisease-Free SurvivalSurvival AnalysisCyclosporineFlow CytometryLeukocyte CountBlood DonorsHematologic DiseasesImmunosuppressionSurvival RatePrecursor Cell Lymphoblastic Leukemia-LymphomaCell DifferentiationLymphocyte DepletionCell SeparationPlatelet CountHodgkin DiseaseT-LymphocytesImmunophenotypingNuclear FamilyImmunocompromised HostMyelodysplastic SyndromesCells, CulturedAcute DiseaseFatal OutcomeBlood Group IncompatibilityCytarabineIfosfamideRecombinant ProteinsSalvage TherapyLeukocyte TransfusionEmbryonic Stem CellsLymphomaHLA AntigensLeukocytes, MononuclearAntigens, CDNeoplasmsMice, Inbred C57BLAdult Stem CellsCytomegalovirusVidarabineLeukemia, MyeloidBone RemodelingFollow-Up StudiesPolymerase Chain Reaction